인문학
사회과학
자연과학
공학
의약학
농수해양학
예술체육학
복합학
지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록·키워드
The thoracic branch endoprosthesis (TBE, W. L. Gore & Associates) provides an off-the-shelf endovascular solution for zone 2 aortic pathology that maintains perfusion to the arm. This study evaluates safety and efficacy of percutaneous radial access for subclavian branch treatment during TBE repair. A single-institution retrospective review of consecutive patients who underwent zone 2 aortic repair with TBE between 2022 and 2024 was performed. Treatment indications included acute complicated aortic dissection, aortic dissection with aneurysmal degeneration, penetrating aortic ulcer, blunt thoracic aortic injury, and de novo aneurysmal disease. Sixty-three consecutive patients (66.7% male; mean age, 61.0 ± 16.5 years) underwent zone 2 repair with a TBE device, 29 (46.0%) for aneurysmal disease, 15 (23.8%) for blunt thoracic aortic injury, 17 (27.0%) for dissection, and 2 (3.2%) for penetrating aortic ulcer. Twenty-one (33.3%) were urgent or emergent cases performed within 24 hours of presentation. Side branch treatment was performed through percutaneous left radial access in 60 patients (95.2%). Radial access was technically successful in 100% of attempts without the need for more proximal percutaneous or open upper extremity access. One (1.7%) asymptomatic radial artery occlusion was detected postoperatively, and did not require intervention. Postoperative imaging was obtained before discharge in 58 patients (92.1%), demonstrating 100% subclavian side branch patency. These results demonstrate that left radial access is safe and effective for subclavian branch treatment during thoracic branch endoprosthesis for management of zone 2 aortic pathology.
인공지능 문자 인식 모델을 통해 추출된 텍스트로, 일부 오타나 오류가 포함될 수 있으나 지속적으로 개선 중입니다.
오류를 발견하셨다면 해당 부분을 드래그한 후 ' 를 통해 신고해주세요.
오류를 발견하셨다면 해당 부분을 드래그한 후 ' 를 통해 신고해주세요.